Recent work indicates that neural progenitors can be isolated from the skin of rodents and humans. The persistence of these cells in accessible adult tissue raises the possibility of their exploitation for research and therapeutic purposes. This study reports on the derivation, culture, and characterization of homogenous canine skin-derived neuroprecursor cells (SKiNPs) from mature animals. Canine tissue was used because naturalistic brain diseases in community-dwelling dogs are emerging as ecologically sound models for a range of neurological conditions. Adult SKiNPs were initially isolated as neurospheres and then cultured for 10-15 passages in an adherent monolayer assay. Serumfree expansion conditions contained B-27, 20 ng/mL EGF, and 40 ng/mL bFGF. Gene expressions by PCR indicated expression of nestin, CD133, NCAM, and FGF2R, but not GFAP. Highly uniform expression of nestin (76 ± 8.3%), NCAM (84 ± 3.3%), βIII-tubulin (96 ± 4.3%), and CD133 (68 ± 13.5%) was also observed. Directed differentiation of SKiNPs in the presence of serum induced βIIItubulin, NSE, NCAM, and MAP2 in >90% of differentiated cells by immunophenotype analysis. Our culture system rapidly induces canine skin cells into neural precursors, maintains nestin expression in more than 75% of proliferating cells, and generates an almost universal neuronal-like phenotype after 7 days of in vitro differentiation. Their biological characteristics are suggestive of transiently amplifying fate-restricted neuroprecursors rather than true neural stem cells. This system may be an effective alternative for autologous neurorestorative cell replacement in canine models for further translational research.
Introduction
T hroughout adulthood mammalian skin is constantly regenerated due to an ongoing high rate of cell loss. Skin stem cells are therefore highly proliferative, a characteristic readily evident in in vitro culture [1] . In human skin, different stem cell niches are thought to persist into adulthood. A highly regulated "bulge" microenvironment located adjacent to the hair follicle shaft functions to maintain the cells of the epidermis [2] , while a subpopulation with a latent multi-lineage potential resides at the base of the dermal papillae [3] . The proper physiological function of this niche remains unclear.
Like our own skin, the brain's three major cell types arise from the embryonic ectoderm. The shared ontogenic origin of both skin and brain has therefore spurned interest in the possibility of inducing skin stem cells down the neural pathway. In this study, canine skin was investigated because of increasing recognition that dogs develop many of the same important neurological diseases that affl ict humans in a naturalistic fashion. Canine equivalents of spinal cord injury [4] , stroke [5] , epilepsy [6] , neurometabolic disorders [7] , Alzheimer's disease [8] , parkinsonism [9] , and muscular dystrophy [10] are prime examples.
For future clinical purposes, a skin-derived neural precursor (SKiNP) system is an attractive option because it would allow for an autogenic graft source free from ethical controversy and involving minimal invasiveness [11] . Initial reports from murine tissue found that EGF/FGF-dependent neurospheres could be induced and propagated for over 80 population doublings, were able to proliferate from single-cell clonal conditions, expressed the neural precursor marker nestin, and differentiated in the absence of mitogenic factors to produce both neural and glial cells [12] . Neuronal yields from skin-based protocols, however, have been lowvarying from 6 to 15% β-tubulin-positive cells when derived from either mouse [12] or infant human skin [13, 14) , or from adult human skin when supplemented with undefi ned factors from glia-conditioned media [15] .
One possible reason for the low neuronal yield is that skin-based protocols have so far relied exclusively upon the neurosphere assay for propagation. The neurosphere assay is a highly effective means of generating, amplifying, and studying neural precursors [16, 17) . Potential clinical applications are however limited by the inherent cellular heterogeneity that characterizes neurosphere cytoarchitecture [18] . Quantitative analysis suggests that less than 1% of a given neurosphere's constituent cells are bona fi de neural stem cells [17] . Moreover, complex and dynamic biological interactions continue to occur within the cytosphere mass, including phagocytosis and apoptosis as well as de novo mitosis [19] . By contrast, the two-dimensional simplicity of the adherent monolayer assay appears to favor culture of a more uniform neural precursor population [20, 21) .
Our in vitro strategy aims to take advantage of the strengths of both stem cell culture approaches by fi rst inducing neurosphere formation from a skin biopsy followed by transfer to the monolayer assay under serum free expansion conditions. This dual-assay system allows for the effi cient and effective homogenous culture of canine SKiNPs. This system (1) rapidly induces canine skin cells into neural precursors, (2) doubles cell numbers every 7 days, (3) maintains nestin expression in more than 75% of proliferating cells, and (4) under standard differentiation conditions, generates an almost universal neuronal-like phenotype. Trial of cell replacement strategies using SKiNPs cultured in this way in dogs affected by naturally prevalent neurological conditions may provide valuable insights for the design and conduct of future human studies.
Materials and Methods

Animals
All results are based on three replications from independent cell lines derived from two different domestic dogs. Animals were community-based dogs that underwent routine surgery at Struggletown Veterinary Hospital in Sydney and who had waste skin tissue (1-2 cm 2 ) opportunistically harvested and donated by consenting owners. Skin came from a 2-year-old female Rottweiler and a 4.5-year-old male Blue Terrier and these animals had surgery for conditions unrelated to the skin. The use of canine tissue was approved by the Animal Care and Ethics Committee of The University of New South Wales.
SKiNP isolation and culture
Skin biopsies were immediately transferred in PBS (Gibco, 2 Melbourne, Victoria, Australia) and processed within 1 h. The specimen was chopped into 2-3 mm 2 pieces and washed twice with PBS containing 1% penicillin and streptomycin (Gibco) followed by fresh PBS alone. SKiNPs were isolated according to the modifi ed protocol of Toma et al. [12] . Briefl y, tissue was digested with 0.1% DNAse (Roche Applied Science, Castle Hill, NSW, Australia) for 1 min followed with 0.1% trypsin for 40 min at 37°C, then mechanically dissociated and fi ltered through a 40 μm cell strainer (Falcon, BD Biosciences, San Diego, CA). Dissociated cells were placed in serum-free DMEM-F12 (3:1; Invitrogen, Carlsbad, CA), which contained 20 ng/mL EGF (BD Biosciences), 40 ng/mL bFGF (Invitrogen), and 2% B27 (Gibco) at 37°C/5% CO 2 . SKiNPs were initially cultured as neurospheres, which formed within 1-5 days after isolation (<20 μm). When most neurospheres reached 70 μm in diameter, they were mechanically dissociated to form single cells, which were seeded onto gelatin-coated fl asks and grown as an adherent monolayer. When 75% confl uence was reached (usually within 1-2 weeks), SKiNPs were passaged using TripLE Select (Gibco). SKiNPs were cryopreserved and thawed successfully by using a standardized in-house slow freezing procedure [22] .
Directed differentiation of canine SKiNP towards a neuronal lineage
After a different number of passages, dog SKiNPs were grown on glass cover slips pre-coated with laminin (24 h, 5 μg/cm 2 ; Invitrogen) in 24-well culture plates (initial plating density 2 × 10 4 cells/well). SKiNPs were allowed to attach and form a monolayer using serum-free DMEM-F12 (3:1) media supplemented with 20 ng/mL EGF and 40 ng/mL bFGF before being subject to the differentiation protocol. After 3 days, cells were allowed to differentiate by removing EGF and bFGF and supplementing the media with 3% FBS (Invitrogen) for 7 days or 3% FBS plus 10 ng/mL BDNF (Invitrogen) for 21 days. Media were changed every 3 days.
RT-PCR analysis
Total RNA was extracted from canine SKiNP at different passages by using RNeasy Minikit (Qiagen, Doncaster, Australia) with DNase 1 treatment (Qiagen), according to the manufacturer's instructions. Complementary DNA (cDNA) was synthesized from 1 μg of total RNA in 20 μL reaction mixture using Superscript III RT First Strand Synthesis System (Invitrogen) using oligo(dT) as a primer according to the manufacturer's instructions. PCR amplifi cation was carried out using the Platinum Taq DNA Polymerase (Invitrogen). Primer sequences, lengths of amplifi ed products, and amplifi cation conditions are listed in Table 1 . Products were analyzed on a 1% agarose gel (Ultrapure agarose; Invitrogen) and visualized by SYBR green (Invitrogen).
Immunofluorescence analysis
SKiNPs on laminin-coated cover slips were washed with PBS (Gibco), and then fi xed in freshly prepared 4% paraformaldehyde for 20 min at room temperature. Cells were then washed twice in PBS/0.1% Tween-20 (PBST) solution and permeabilized with 0.1% Triton X-100/PBS for 10 min, as described previously [23] . The cells were subsequently washed twice in PBST solution, and non-specifi c sites were blocked with 2% bovine serum albumin (BSA; 3   136  137  138  139  140  141  142  143  144  145  146  147  148  149  150  151  152  153  154  155  156  157  158  159  160  161  162  163  164  165  166  167  168  169  170  171  172  173   174  175  176  177  178   179  180  181  182  183  184  185  186  187  188  189  190   191  192  193  194  195  196  197   198  199 Sigma, St. Louis, MO) in PBST for 1 h at room temperature. Cells were incubated with primary antibodies for 1 h at room temperature. After washing with PBST solution three times for 2 min each, the secondary antibody conjugated to either FITC or TRITC (1:500, AlexaFluor 488 or 594; Molecular Probes, Melbourne, Australia) was applied for 30 min at room temperature. The cells were washed with PBST three times at 2 min each wash, and the nuclei stained with 4′ 6-diamidino-2-phenylindole (Prolong Gold anti-fade reagent with DAPI; Invitrogen) for 5 min. Omitting the primary antibodies were used as negative controls. Primary antibodies and dilutions used were βIII-tubulin rabbit polyclonal antibody (1:1000; Covance, Berkeley, CA), CD133 rabbit polyclonal antibody (1:100; Abcam, Cambridge, United Kingdom), MAP2 (1:1000; Covance), NCAM mouse monoclonal antibody (1:500; Covance), nestin mouse monoclonal antibody (1:200; Chemicon, Boronia, Australia), and NSE rabbit polyclonal antibody (1:200; Abcam).
NEURAL PRECURSORS FROM CANINE SKIN
Images were collected using a digital camera mounted onto an immunofl uorence microscope (Carl Zeiss MicroImaging GmbH, Sachsen, Thüringen, Jena, Germany) and analyzed using the image software Axiovision (v. 4.6, Carl Zeiss Vision). Semi-automated cell counting was carried out using CellProfi ler [24] , an open source freeware package (v. 1.0.4828 <www.cellprofi ler.com>). For each phenotype marker, at least three random frames (each with more than 20 cells) from two different experiments on independent cell lines were analyzed. CellProfi ler allows for the automatic calculation of cell number via nuclei extraction and quantifi cation. An optimized cell outline is then generated for each nucleus based on the intensity and distribution of peri-nuclear immunostaining. Individual framewise thresholds for overall immunostain intensity and immunostain intensity/cell area were then established on the basis of a consensus selection of representative cells considered to be either immuno-positive or -negative. Application of these thresholds across the entire frame then allowed automatic quantifi cation of positive and negative cells.
Statistical analysis
All data are presented as mean ± standard deviation. Comparison between two groups was performed using two-sample student's t-test, with p < 0.05 being statistically signifi cant. Statistical analyses were performed using SPSS (v. 14.0 for Windows software).
Results
Morphology
SKiNPs were initially cultured as small neurospheres (diameter <20 μm), which appear within 1-5 days after isolation. When most neurospheres reach 70 μm in diameter (Fig. 1A) , they were dispersed enzymatically and grown as an adherent monolayer that showed a typical bipolar "batwing" formation (Fig. 1B) .
These SKiNPs have now been passaged up to 12 population doublings, with passages 1-7 exhibiting a doubling time of ~7 days, while later passages slowed to 14 days (Fig. 3F) . Adherent SKiNPs that are enzymatically dissociated and suspended in expansion media in uncoated fl asks readily reform neurospheres (Fig. 1C) .
Gene expression
RT-PCR analysis of SKiNPs across passages 1-11 reveal expression of a number of neural precursors: NCAM, βIII-tubulin, and NSE, as well as stem cell markers nestin, CD133, and FGF-2 receptor (Fig. 2) . Expression of GFAP was absent in expansion cultures taken from passages 1 to 11. These results have been replicated across two different cell lines, with PCR performed three times for each sample. Figure 3 shows the immunofl uorescent staining and quantifi cation of SKiNPs in adherent expansion culture. 
Homogeneity and immunofluorescent studies
In vitro differentiation
SKiNPs at passage 6 were differentiated on laminincoated cover slips for 7 days by adding 3% FBS and removing EGF and bFGF from the DMEM-F12 media (Fig. 4) . Quantitative phenotyping after 7 days of differentiation showed that >90% of the SKiNPs were positive for NCAM (97 ± 0.2%; Fig. 4A ), βIII-tubulin (90 ± 5.3%; Fig. 4B ), MAP2 (92 ± 0.8%; Fig. 4C ), and NSE (97 ± 0.2%; Fig. 4D) .
In order to assess the characteristics of a more mature neural phenotype, SkiNPs at passage 7 were differentiated for 21 days after the addition of 10 ng/mL BDNF to the differentiation protocol. On the basis of immunotypic quantitation, there was no change in the percentage of cells expressing MAP2 (91 ± 5.1%, t value = 0.3, p = 0.78).
Discussion
We report here for the fi rst time the isolation, uniform expansion, and characterization of neural precursors from mature adult dog skin. Self-renewal of canine SkiNPs propagated with our dual-assay system was clearly evident across more than 10 passages. Importantly, proliferation appeared to be effi cient enough to be clinically practical: an initial tissue sample of ~3 cm 3 generates the fi rst confl uent adherent culture of ~10 6 cells after 10 days, which then continues to double every week. There was, however, evidence that proliferation rates slowed after passage 7. Given transplantation of pluripotential embryonic stem cells in the mammalian brain has seen development of uncontrolled growth [25] and teratoma formation [26] , the onset of terminal differentiation within a circumscribed number of cell cycles may prove advantageous. therefore suggests that our system favors propagation of a more uniform neuroprecursor population. As mentioned, this has been a potential limitation of previous skin-to-neuron studies, which have relied on neurosphere propagation. This may also explain why previous reports have yielded neuronal differentiation levels below 16%. By contrast, our SKiNP culture method produced over 90% neural-like cells after 7 days of differentiation. This result was underscored Gene expression of our canine SKiNPs was similar to the profi le noted for neural stem cells derived from conventional sources, including nestin and CD133 markers [27] [28] [29] . Nestin and CD133 were also highly conserved across passage number, with phenotypic expression rates between 67 and 76%. Expression of the immature neural protein, βIII-tubulin, was particularly high at over 95% under serum-free expansion conditions. Quantitative immunocytochemistry 247  248  249  250  251  252  253  254  255  256  257  258  259  260  261  262  263  264  265  266  267  268  269  270  271  272  273  274  275  276   277  278  279  280  281  282  283  284  285  286  287  288  289  290  291  292  293  294  295  296  297  298  299  300  301  302  303  304  305  306 is unclear whether the neuronal-like phenotype witnessed in vitro will translate into a greater level of neuronal differentiation in vivo until transplantation studies are completed. However as a general principle, a greater level of neuronal yield in vitro is preferable. Belicchi and co-workers [14] have previously propagated CD133+ neurospheres clonally derived from mouse skin and found that 15% of cells were positive for nestin and βIII-tubulin and 75% positive for GFAP after 7 days of differentiation in vitro. Two months after intraventricular transplantation into immunodeficient mice, donor cells migrated throughout the striatum and cortex with a predominant (>75%) glial GFAP positive phenotype. By contrast, our SKiNPs did not express GFAP mRNA at any stage and showed a high degree of viability over an extended in vitro differentiation period. There was also no evidence of alteration to the high neuronal profi le after longer-term differentiation. It is unknown whether a homogenous SKiNP cell transplant would remain viable in the adult CNS, nor integrate into complex in situ neural networks. This is an area of obvious future interest.
The wider implication of a serum-free technique for the effi cient isolation and propagation of neural precursors from canine skin is the opportunity to test their therapeutic potential in community-based dogs. Interest in canine stem cell science is increasing [32] . Unlike rodents, dogs develop many of the same neurological injuries and diseases as humans in a naturalistic manner [33] . Like their human masters, dogs are also living longer and suffering from more age-related neurological conditions. Concerned dog owners may therefore be open to the possibility of testing cell-based by phenotypic cell profi les of over 90% from three different neural markers, including βIII-tubulin, NSE, and MAP2.
Thus our SKiNP results differ from previous studies in a number of ways. Firstly, proliferative senescence appears to be more marked. Second, during propagation there appeared to be no glial cell expression. Rather, a homogenous population of cells expressing neural stem cell markers was readily amplifi ed and produced a neuronal-like yield 7-10 times more effi cient than previously reported after a standard differentiation protocol. Next, evidence of neural precursor markers and neural-like cells were obtained from trunk skin as opposed to facial skin of neural crest origins [12, 30] . Finally, the multi-lineage potential reported in previous differentiation studies does not appear to be recapitulated; neural-like cells were almost exclusively generated. The biological nature of the SKiNP cells expanded in our dual-assay system would therefore appear to more closely resemble a transiently amplifying fate-restricted neuroprogenitor cell than a bona fi de neural stem cell [31] . Why our results differ in these important ways are unclear; however the novel species' origins of the adult canine skin that was used, and the application of our two-step assay system, are suggested as possible factors.
The high neurogenic potential that we observed was primarily based on PCR expression and immunocytochemical phenotype analyses. These results require further elaboration via electrophysiological and receptor expression studies. While a clinically practical, autologous, homogenous, and effi cient system of neural precursor culture that avoids glial differentiation would be of great signifi cance, it
FIG. 4.
Immunofl uorescent staining of canine SKiNPs differentiated for 7 days. SKiNPs at passage 6 differentiated on laminincoated cover slips using 3% FBS. Cells were immuno-positive (green) for βIII-tubulin (A and B) , MAP2 (C and D), and NSE (E and F) with the nuclei stained with DAPI (blue). interventions when certain criteria are met, including: (1) when supported by a clear scientifi c rationale, (2) when the alternative is likely to be euthanasia, (3) when treatment success will extend quality of life, and (4) when chances of further pain and injury is low. Therefore, the establishment of a reliable protocol for the effi cient and predictable culture of neural precursors from adult canine skin may accelerate clinical neuroscience interest in working with dogs as translational models for test of cell-based therapy, and so expedite the success of future human clinical trials.
